- Home
- CTSO vs GMM Comparison
CTSO vs GMM Comparison
Compare CTSO & GMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- GMM
- Stock Information
- Founded
- CTSO 1997
- GMM 2017
- Country
- CTSO United States
- GMM China
- Employees
- CTSO N/A
- GMM N/A
- Industry
- CTSO Medical/Dental Instruments
- GMM
- Sector
- CTSO Health Care
- GMM
- Exchange
- CTSO Nasdaq
- GMM Nasdaq
- Market Cap
- CTSO 65.7M
- GMM 61.9M
- IPO Year
- CTSO N/A
- GMM 2023
- Fundamental
- Price
- CTSO $0.95
- GMM $2.61
- Analyst Decision
- CTSO Buy
- GMM
- Analyst Count
- CTSO 2
- GMM 0
- Target Price
- CTSO $5.50
- GMM N/A
- AVG Volume (30 Days)
- CTSO 93.3K
- GMM 20.8K
- Earning Date
- CTSO 08-07-2025
- GMM 08-08-2025
- Dividend Yield
- CTSO N/A
- GMM N/A
- EPS Growth
- CTSO N/A
- GMM 62.17
- EPS
- CTSO N/A
- GMM 6.37
- Revenue
- CTSO $35,332,238.00
- GMM $41,360,953.00
- Revenue This Year
- CTSO $11.15
- GMM N/A
- Revenue Next Year
- CTSO $21.39
- GMM N/A
- P/E Ratio
- CTSO N/A
- GMM $0.41
- Revenue Growth
- CTSO 15.37
- GMM 53.82
- 52 Week Low
- CTSO $0.71
- GMM $1.69
- 52 Week High
- CTSO $1.61
- GMM $15.60
- Technical
- Relative Strength Index (RSI)
- CTSO 39.94
- GMM 46.35
- Support Level
- CTSO $0.91
- GMM $2.53
- Resistance Level
- CTSO $1.06
- GMM $3.09
- Average True Range (ATR)
- CTSO 0.06
- GMM 0.24
- MACD
- CTSO -0.01
- GMM -0.02
- Stochastic Oscillator
- CTSO 13.97
- GMM 19.44
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About GMM Global Mofy Metaverse Limited
Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.